Anthem said on Thursday it intends to change its name to Elevance Health as the company looks to shift its focus beyond the health insurance business, reported Reuters.
The US health insurer’s rebranding move is not its first, having previously changed its identity from WellPoint Inc around eight years ago.
The rebranding is a first step in the company’s effort to optimize its brand portfolio, the insurer said in a statement. Anthem’s Blue Cross Blue Shield health plans will not be renamed, it added.
The company, which operates Blue Cross Blue Shield plans in several states, has been attempting to compete in a changing health insurance landscape following deals by rivals such as Cigna to merge with the biggest US pharmacy benefits managers (PBMs).
Anthem launched its in-house pharmacy benefits management business, IngenioRx, in 2019 after ending a long-standing deal with Express Scripts Holding Co, which is now a part of Cigna.
Anthem and Cigna were themselves slated to come together in 2017. However, the deal was scuppered following disagreements between the companies regarding control of the resulting firm, which would have become the world’s largest insurer. Cigna attempted to charge Breach of Contract against Anthem, claiming over $1.8 billion in damages.
The merger agreement called for Anthem, which runs Blue Cross and Blue Shield insurance plans, to acquire Cigna. Anthem also filed a breach-of-contract suit, in which it accused Cigna of undermining the transaction by working to help the government’s antitrust case.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI